Sara Bonstein
2018 - OncoSec Medical
In 2018, Sara Bonstein earned a total compensation of $919.2K as Chief Financial Officer and Chief Operating Officer at OncoSec Medical.
Compensation breakdown
| Bonus | $75,000 |
|---|---|
| Salary | $6,731 |
| Stock Awards | $837,500 |
| Total | $919,231 |
Bonstein received $837.5K in stock awards, accounting for 91% of the total pay in 2018.
Bonstein also received $75K in bonus and $6.7K in salary.
Rankings
In 2018, Sara Bonstein's compensation ranked 9,602nd out of 14,244 executives tracked by ExecPay. In other words, Bonstein earned more than 32.6% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,602 out of 14,244 | 33rd |
Division Manufacturing | 3,862 out of 5,765 | 33rd |
Major group Chemicals And Allied Products | 1,457 out of 2,128 | 32nd |
Industry group Drugs | 1,227 out of 1,817 | 33rd |
Industry Pharmaceutical Preparations | 946 out of 1,391 | 32nd |
Source: SEC filing on November 8, 2018.
Bonstein's colleagues
We found three more compensation records of executives who worked with Sara Bonstein at OncoSec Medical in 2018.